These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Sato S; Li K; Kameyama T; Hayashi T; Ishida Y; Murakami S; Watanabe T; Iijima S; Sakurai Y; Watashi K; Tsutsumi S; Sato Y; Akita H; Wakita T; Rice CM; Harashima H; Kohara M; Tanaka Y; Takaoka A Immunity; 2015 Jan; 42(1):123-32. PubMed ID: 25557055 [TBL] [Abstract][Full Text] [Related]
5. Therapy of chronic hepatitis B: new goals and new treatments. Mauss S Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480 [TBL] [Abstract][Full Text] [Related]
6. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond? Schreiner S; Nassal M Viruses; 2017 May; 9(5):. PubMed ID: 28531167 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes. Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879 [TBL] [Abstract][Full Text] [Related]
8. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. Gregorio GV; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G; Vergani D J Immunol; 1999 Feb; 162(3):1802-10. PubMed ID: 9973445 [TBL] [Abstract][Full Text] [Related]
9. Entecavir for the long-term treatment of chronic hepatitis B. Gonzalez SA; Keeffe EB Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1053-62. PubMed ID: 19883325 [TBL] [Abstract][Full Text] [Related]
10. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. Tu T; Mason WS; Clouston AD; Shackel NA; McCaughan GW; Yeh MM; Schiff ER; Ruszkiewicz AR; Chen JW; Harley HA; Stroeher UH; Jilbert AR J Viral Hepat; 2015 Sep; 22(9):737-53. PubMed ID: 25619231 [TBL] [Abstract][Full Text] [Related]
11. The new insight into management of hepatitis B virus patients with flare. Tavakolpour S Immunol Lett; 2016 May; 173():77. PubMed ID: 26903195 [No Abstract] [Full Text] [Related]
12. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo. Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689 [TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B: current challenges and future directions. Chin R; Locarnini S Rev Med Virol; 2003; 13(4):255-72. PubMed ID: 12820187 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic hepatitis B]. Mauss S MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564 [No Abstract] [Full Text] [Related]
15. [New Strategy for anti-HBV therapy: blocking P-8 interaction]. Huang YY; Hu KH Bing Du Xue Bao; 2014 Nov; 30(6):713-20. PubMed ID: 25868288 [TBL] [Abstract][Full Text] [Related]
16. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Allweiss L; Volz T; Giersch K; Kah J; Raffa G; Petersen J; Lohse AW; Beninati C; Pollicino T; Urban S; Lütgehetmann M; Dandri M Gut; 2018 Mar; 67(3):542-552. PubMed ID: 28428345 [TBL] [Abstract][Full Text] [Related]
18. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B. Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059 [TBL] [Abstract][Full Text] [Related]
19. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region. Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Chou YC; Chen ML; Hu CP; Chen YL; Chong CL; Tsai YL; Liu TL; Jeng KS; Chang C Hepatology; 2007 Sep; 46(3):672-81. PubMed ID: 17580335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]